Efficacy of adding levofoxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: Study protocol for a multicenter, randomized phase 2 trial (T-CORE2201)
7
0
0
8 trang
